The renoprotective effect of curcumin in cisplatin-induced nephrotoxicity

Renal Failure

Volumn 37, Issue 2, 2015, Pages 332-336

  Ugur, Siddik ^a   Ulu, Ramazan ^a   Dogukan, Ayhan ^a   Gurel, Ali ^a   Yigit, Irem Pembegul ^a   Gozel, Nevzat ^a   Aygen, Bilge ^a   Ilhan, Necip ^a  

^a FIRAT UNIVERSITY   (Turkey)

Author keywords

Cisplatin; Curcumin; Nephrotoxicity; Oxidative stress; Sirtuin

Indexed keywords

CISPLATIN; CREATININE; CURCUMIN; MALONALDEHYDE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; SIRTUIN 1; SIRTUIN 3; SIRTUIN 4; UREA; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; ANTIOXIDANT; GLUTATHIONE; SIRTUIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; KIDNEY INJURY; KIDNEY PARENCHYMA; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; UREA BLOOD LEVEL; ANIMAL; BLOOD; CHEMICALLY INDUCED; KIDNEY; KIDNEY DISEASES; METABOLISM; PATHOLOGY; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL; WISTAR RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; BLOOD UREA NITROGEN; CISPLATIN; CREATININE; CURCUMIN; GLUTATHIONE; KIDNEY; KIDNEY DISEASES; MALE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; RATS; RATS, WISTAR; SIRTUINS; TREATMENT OUTCOME;

EID: 84923121157     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2014.986005     Document Type: Article

References (44)

1. Rosenberg B. Fundamental studies with cisplatin. Cancer. 1985;55(10):2303-23l6.
2. Giaccone G. Clinical perspectives on platinum resistance. Drugs. 2000;59(4)(suppl):S9-S17.
3. Yilmaz HR, Iraz M, Sogut S, et al. The effects of erdosteine on the activities of some metabolic enzymes during cisplatin-induced nephrotoxicity in rats. Pharmacol Res. 2004;50(3):287-290.
4. Kaushal GP, Kaushal V, Hong X, Shah SV. Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cells. Kidney Int. 2001;60(5):1726-1736.
5. Lee HS, Kim BK, Nam Y, et al. Protective role of phosphatidylcholine against cisplatin-induced renal toxicity and oxidative stress in rats. Food Chem Toxicol. 2013;58:388-393.
6. Meyer KB, Madias NE. Cisplatin nephrotoxicity. Miner Electrolyte Metab. 1994;20(4):201-213.
7. Tanaka H, Ishikawa E, Teshima S, Shimizu E. Histopathological study of human cisplatin nephropathy. Toxicol Pathol. 1986;14(2):247-257.
8. Zhou H, Kato A, Miyaji T, et al. Urinary marker for oxidative stress in kidneys in cisplatin-induced acute renal failure in rats. Nephrol Dial Transplant. 2006;21(3):616-623.
9. Esatbeyoglu T, Huebbe P, Ernst IM, Chin D, Wagner AE, Rimbach G. Curcumin-from molecule to biological function. Angew Chem Int Ed Engl. 2012;51(22):5308-5332.
10. Reddy AC, Lokesh BR. Studies on the inhibitory effects of curcumin and eugenol on the formation of reactive oxygen species and the oxidation of ferrous iron. Mol Cell Biochem. 1994;137:1-8.
11. Reddy AC, Lokesh BR. Studies on spice principles as antioxidants in the inhibition of lipid peroxidation of rat liver microsomes. Mol Cell Biochem. 1992;111(1-2):117-124.
12. Cohly HH, Taylor A, Angel MF, Salahudeen AK. Effect of turmeric, turmerin and curcumin on H2O2-induced renal epithelial (LLC-PK1) cell injury. Free Radic Biol Med. 1998;24(1):49-54.
13. Kelly G. A review of the sirtuin system, its clinical implications, and the potential role of dietary activators like resveratrol: Part 1.Altern Med Rev. 2010;15(3):245-263.
14. Oberdoerffer P, Michan S, McVay M, et al. SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging. Cell. 2008;135(5):907-918.
15. Revollo JR, Grimm AA, Imai S. The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. J Biol Chem. 2004;279(49):50754-50763.
16. Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular disease: Pathophysiology, evaluation, and effect of weight loss: An update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2006;113(6):898-918.
17. Garten A, Petzold S, Körner A, Imai S, Kiess W. Nampt: Linking NAD biology, metabolism and cancer. Trends Endocrinol Metab. 2009;20(3):130-138.
18. Karatepe M. Simultaneous determination of ascorbic acid and free malondialdehyde in human serum by HPLC/UV. LCGC N Am. 2004;22:362-365.
19. Wong YT, Ruan R, Tay FE. Relationship between levels of oxidative DNA damage, lipid peroxidation and mitochondrial membrane potential in young and old F344 rats. Free Radic Res. 2006;40(4):393-402.
20. Dogukan A, Tuzcu M, Agca CA, et al. A tomato lycopene complex protects the kidney from cisplatin-induced injury via affecting oxidative stress as well as Bax, Bcl-2, and HSPs expression. Nutr Cancer. 2011;63(3):427-434.
21. Ulu R, Dogukan A, Tuzcu M, et al. Regulation of renal organic anion and cation transporters by thymoquinone in cisplatin induced kidney injury. Food Chem Toxicol. 2012;50(5):1675-1679.
22. Pabla N, Dong Z. Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies. Kidney Int. 2008;73(9):994-1007.
23. Surendiran A, Balamurugan N, Gunaseelan K, Akhtar S, Reddy KS, Adithan C. Adverse drug reaction profile of cisplatinbased chemotherapy regimen in a tertiary care hospital in India: An evaluative study. Indian J Pharmacol. 2010;42(1):40-43.
24. Hanigan MH, Devarajan P. Cisplatin nephrotoxicity: Molecular mechanisms. Cancer Ther. 2003;1:47-61.
25. Chirino YI, Pedraza-Chaverri J. Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity. Exp Toxicol Pathol. 2009;61(3):223-242.
26. Cohly HH, Taylor A, Angel MF, Salahudeen AK. Effect of turmeric, turmerin and curcumin on H2O2-induced renal epithelial (LLC-PK1) cell injury. Free Radic Biol Med. 1998;24(1):49-54.
27. Antunes LM, Darin JD, Bianchi Nde L. Effects of the antioxidants curcumin or selenium on cisplatin-induced nephrotoxicity and lipid peroxidation in rats. Pharmacol Res. 2001;43(2):145-150.
28. Sahin K, Orhan C, Tuzcu M, et al. Comparative in vivo evaluations of curcumin and its analog difluorinated curcumin against cisplatin-induced nephrotoxicity. Biol Trace Elem Res. 2014;157(2):156-163.
29. Revollo JR, Grimm AA, Imai S. The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals. Curr Opin Gastroenterol. 2007;23(2):164-170.
30. Luk T, Malam Z, Marshall JC. Pre-B cell colony-enhancing factor (PBEF)/visfatin: A novel mediator of innate immunity. J Leukoc Biol. 2008;83(4):804-816.
31. Tsujimoto Y. Apoptosis and necrosis: Intracellular ATP level as a determinant for cell death modes. Cell Death Differ. 1997;4(6):429-434.
32. Carling D. The AMP-activated protein kinase cascade-a unifying system for energy control. Trends Biochem Sci. 2004;29(1):18-24.
33. Zhao S, Xu W, Jiang W, et al. Regulation of cellular metabolism by protein lysine acetylation. Science. 2010;327(5968):1000-1004.
34. Finkel T, Deng CX, Mostoslavsky R. Recent progress in the biology and physiology of sirtuins. Nature. 2009;460(7255):587-591.
35. Ahuja N, Schwer B, Carobbio S, et al. Regulation of insulin secretion by SIRT4, a mitochondrial ADP-ribosyltransferase. J Biol Chem. 2007;282(46):33583-33592.
36. Haigis MC, Mostoslavsky R, Haigis KM, et al. SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells. Cell. 2006;126(5):941-954.
37. Vaziri H, Dessain SK, Ng Eaton E, et al. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell. 2001;107(2):149-159.
38. Jeong J, Juhn K, Lee H, et al. SIRT1 promotes DNA repair activity and deacetylation of Ku70. Exp Mol Med. 2007;39(1):8-13.
39. Yeung F, Hoberg JE, Ramsey CS, et al. Modulation of NFkappaBdependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 2004;23(1):2369-2380.
40. Arsenijevic D, Onuma H, Pecqueur C, et al. Disruption of then uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nat Genet. 2000;26(4):435-439.
41. Hallows WC, Lee S, Denu JM. Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases. Proc Natl Acad Sci USA. 2006;103(27):10230-10235.
42. Ahn BH, Kim HS, Song S, et al. A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proc Natl Acad Sci USA. 2008;105(38):14447-14452.
43. Kong X, Wang R, Xue Y, et al. Sirtuin 3, a new target of PGC-1alpha, plays an important role in the suppression of ROS and mitochondrial biogenesis. PLoS One. 2010;5(7):11707.
44. Jung YJ, Lee JE, Lee AS, et al. SIRT1 overexpression decreases cisplatin-induced acetylation of NF-kB p65 subunit and cytotoxicity in renal proximal tubule cells. Biochem Biophys Res Commun. 2012;419(2):206-210.